Brazilian Journal of Infectious Diseases (Mar 2010)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C

  • Aline Gonzalez Vigani, MD, PhD,
  • Maria H.P. Pavan,
  • Raquel Tozzo,
  • Eduardo S.L. Gonçales,
  • Maria S.K. Lazarini,
  • Alexandre Macedo de Oliveira,
  • Fernando L. Gonçales, Jr

Journal volume & issue
Vol. 14, no. 2
pp. 193 – 196

Abstract

Read online

Hemodialysis patient with chronic HCV infection, who was started on monotherapy with interferon. Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment. Keywords: hepatitis C virus, hemodialysis, treatment, interferon, ribavirin